Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1351421
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1351421
Pharma 4.0 Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 288 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Pharma 4.0 Market size was valued at USD 10,900 Million in 2022, expanding at a CAGR of 17.7% from 2023 to 2030.
Pharma 4.0 represents the integration of cutting-edge digital technologies, data analytics, robotics, and artificial intelligence into the pharmaceutical industry, aligning with the principles of the fourth industrial revolution. This transformative concept aims to revolutionize various facets of the pharmaceutical sector, encompassing drug research, development, manufacturing, and patient care. Its overarching goals include bolstering operational efficiency, expediting innovation, optimizing supply chain operations, and facilitating the implementation of personalized medicine.
Pharma 4.0 aspires to streamline processes, elevate product quality, and empower agile decision-making processes by harnessing the power of real-time data-driven insights, predictive modeling, and the interconnectivity of smart systems. Ultimately, it strives to usher in an era of healthcare that revolves around the patient, delivering more patient-centric and sustainable solutions. In doing so, it embraces technological innovations to effectively address the ever-evolving challenges and opportunities within the pharmaceutical landscape.
Pharma 4.0 Market - Market Dynamics:
- Increasing pressure to accelerate drug development and bring new therapies to propel market demand
- The pharmaceutical industry grapples with mounting challenges in addressing intricate diseases and meeting evolving patient needs with expediency. The advent of Pharma 4.0 has ushered in a new era, offering more efficient avenues for drug development, predictive modeling for clinical trials, and enhanced production processes. This transformation hinges on the integration of advanced technologies such as artificial intelligence, machine learning, and data analytics.
- Pharma 4.0 not only delivers notable time and cost savings but also enhances the industry's adaptability in responding to emergent health crises, regulatory shifts, and shifting consumer demands. Consequently, it fosters a climate of accelerated innovation and improved accessibility to groundbreaking, life-saving therapies, ushering in a new era of healthcare for patients.
Pharma 4.0 Market - Key Insights:
- According to insights shared by our research analyst, the global Pharma 4.0 market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 18.2% during the forecast period spanning from 2023 to 2030.
- This industry's expansion is underpinned by significant factors, most notably the mounting pressure to expedite drug development processes and introduce novel therapies to market.
- Within the context of Technology segmentation, Artificial Intelligence emerges as the standout category, capturing the majority of the market share for the year 2022.
- Furthermore, in the realm of application segmentation, Clinical Trials takes the lead in 2022, underscoring the pivotal role of Pharma 4.0 in optimizing and expediting clinical research processes.
- From a regional perspective, North America emerges as the primary revenue contributor in the year 2022, reflecting the region's commitment to embracing Pharma 4.0 as a means to drive innovation and enhance healthcare outcomes.
Pharma 4.0 Market- Segmentation Analysis:
- The Global Pharma 4.0 Market exhibits a multifaceted segmentation structure, comprising Technology, Application, End-User, and Geographical Region as its primary divisions.
- Under the umbrella of Technology classification, the market delineates three distinct categories: Cloud Computing, Artificial Intelligence, Big Data Analytics, and the Internet of Things. Remarkably, it is the Artificial Intelligence sector that asserts its dominance, emerging as the predominant force within the market.
- Pharma 4.0 harnesses the capabilities of artificial intelligence (AI) to usher in a transformative era for the pharmaceutical sector. AI-powered algorithms are instrumental in deciphering complex datasets, expediting drug research, offering predictive insights into clinical trial outcomes, and optimizing production processes. This symbiotic relationship between AI and Pharma 4.0 fosters a paradigm shift characterized by enhanced decision-making, heightened innovation, and the adoption of patient-centric approaches. Ultimately, this synergy results in a healthcare ecosystem that is not only more productive but also highly responsive to evolving healthcare needs.
Pharma 4.0 Market- Competitive Landscape:
Pharma 4.0's competitive landscape is a dynamic arena characterized by the convergence of established pharmaceutical giants and innovative startups. While industry stalwarts like Pfizer, Novartis, and Roche commit substantial resources to embrace the digital transformation, a wave of niche players and technology startups with expertise in AI, data analytics, and automation are making their mark by introducing disruptive solutions.
In this landscape, a noteworthy trend is the collaborative spirit between pharmaceutical firms and technology providers. They are forging partnerships and alliances, fostering a culture of innovation. The competition in the burgeoning Pharma 4.0 market is centered on the establishment of robust data platforms, sophisticated analytics capabilities, and agile manufacturing systems. These endeavors aim to confer a competitive edge by accelerating drug discovery, optimizing supply chains, and delivering personalized healthcare solutions to meet the evolving needs of the healthcare ecosystem.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMA 4.0 MARKET KEY PLAYERS
- Pfizer Inc.
- Roche Holding AG
- Novartis AG
- Johnson & Johnson
- GlaxoSmithKline plc
- Sanofi S.A.
- AstraZeneca plc
- Merck & Co., Inc.
- Eli Lilly and Company
- AbbVie Inc.
- Boehringer Ingelheim International GmbH
- Takeda Pharmaceutical Company Limited
- Bristol Myers Squibb Company
- Moderna, Inc.
- Regeneron Pharmaceuticals, Inc.
GLOBAL PHARMA 4.0 MARKET, BY TECHNOLOGY
- Cloud Computing
- Artificial Intelligence
- Big Data Analytics
- Internet of Things
GLOBAL PHARMA 4.0 MARKET, BY APPLICATION
- Drug Discovery and Development
- Clinical Trials
- Manufacturing
GLOBAL PHARMA 4.0 MARKET, BY END-USER
- Pharmaceutical Companies
- Biotechnology Companies
- CROs and CMOs
GLOBAL PHARMA 4.0 MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1656
Table of Contents
1. Pharma 4.0 Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Pharma 4.0 Market Snippet by Technology
- 2.1.2. Pharma 4.0 Market Snippet by Application
- 2.1.3. Pharma 4.0 Market Snippet by End-User
- 2.1.4. Pharma 4.0 Market Snippet by Country
- 2.1.5. Pharma 4.0 Market Snippet by Region
- 2.2. Competitive Insights
3. Pharma 4.0 Key Market Trends
- 3.1. Pharma 4.0 Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Pharma 4.0 Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Pharma 4.0 Market Opportunities
- 3.4. Pharma 4.0 Market Future Trends
4. Pharma 4.0 Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Pharma 4.0 Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Pharma 4.0 Market Landscape
- 6.1. Pharma 4.0 Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Pharma 4.0 Market - By Technology
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 7.1.2. Cloud Computing
- 7.1.3. Artificial Intelligence
- 7.1.4. Big Data Analytics
- 7.1.5. Internet of Things
8. Pharma 4.0 Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Drug Discovery and Development
- 8.1.3. Clinical Trials
- 8.1.4. Manufacturing
9. Pharma 4.0 Market - By End-User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
- 9.1.2. Pharmaceutical Companies
- 9.1.3. Biotechnology Companies
- 9.1.4. CROs and CMOs
10. Pharma 4.0 Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Pharma 4.0 Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Pharma 4.0 Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Pharma 4.0 Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Pharma 4.0 Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Pharma 4.0 Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Pharma 4.0 Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Roche Holding AG
- 11.2.3. Novartis AG
- 11.2.4. Johnson & Johnson
- 11.2.5. GlaxoSmithKline plc
- 11.2.6. Sanofi S.A.
- 11.2.7. AstraZeneca plc
- 11.2.8. Merck & Co., Inc.
- 11.2.9. Eli Lilly and Company
- 11.2.10. AbbVie Inc.
- 11.2.11. Boehringer Ingelheim International GmbH
- 11.2.12. Takeda Pharmaceutical Company Limited
- 11.2.13. Bristol Myers Squibb Company
- 11.2.14. Moderna, Inc.
- 11.2.15. Regeneron Pharmaceuticals, Inc.
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1656
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Pharma 4.0 Market: Technology Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Technology
- TABLE Global Pharma 4.0 Market, by Technology 2018-2030 (USD Million)
- TABLE Pharma 4.0 Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Pharma 4.0 Market, by Application 2018-2030 (USD Million)
- TABLE Pharma 4.0 Market: End-User Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by End-User
- TABLE Global Pharma 4.0 Market, by End-User 2018-2030 (USD Million)
- TABLE Pharma 4.0 Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Pharma 4.0 Market, by Region 2018-2030 (USD Million)
- TABLE North America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
- TABLE North America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
- TABLE North America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
- TABLE North America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
- TABLE Europe Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
- TABLE Europe Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
- TABLE Latin America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
- TABLE Latin America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.